bpc-157 human studies clinical trials safety trial Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D bpc-157 clinical studies safety human

No doubt about storage, no grey zone on accumulated microbial load, no peptide loss in a questionable diluent

This depends entirely on the specific peptides and medications involved

Glutamate, aspartate, and SP released in the SC in response to formalin s.c

A study using Framingham Heart Study data suggested that men in the study appeared to have a lower risk for dementia due to survival bias, in which the men who survived to age 65 or beyond and were included in the study were the ones with a healthier cardiovascular risk profile (men have a higher rate of death from cardiovascular disease in middle age than women) and thus a lower risk for dementia